Abivax Competitors and Similar CompaniesClear all
Abivax's competitors and similar companies include UCB.
 Abivax Abivax is a biotech company that mobilizes the body’s natural immune system to treat patients suffering from inflammatory diseases, infectious diseases, and cancer. |  UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions. | |
Founding Date | Founding Date 2013 | Founding Date 1928 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Paris, FR HQ Montpellier, FR Montpellier, FR Waltham, US | Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more |
Employees | Employees 69 | Employees 9,052 |
Valuation ($) | Valuation ($) 672.6 m | Valuation ($) 34.3 b |
Financial | ||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) €7.4b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods €1.4b (FY, 2025) |
Gross profit | Gross profit €4.6m (FY, 2025) | Gross profit €7.2b (FY, 2025) |
Net income | Net income (€336.1m) (FY, 2025) | Net income €1.6b (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
UCB
HQ
Brussels, BE
Employees
9,052
UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
View company